Dehydroglyasperin D is primarily studied for its potent biological activities, particularly its anti-inflammatory and antioxidant effects. It has shown promise in inhibiting pathways involved in chronic inflammation, making it a candidate for research in inflammatory diseases such as arthritis and inflammatory bowel disease.

The compound also exhibits neuroprotective properties, with studies indicating it may help protect brain cells from oxidative stress and reduce the risk of neurodegenerative conditions like Alzheimer’s disease. Its ability to modulate cellular defense mechanisms enhances its potential in age-related cognitive decline prevention.

Additionally, Dehydroglyasperin D demonstrates anti-cancer activity by inducing apoptosis and suppressing the growth of certain tumor cells in preclinical models, especially in colon and liver cancer lines. It may also contribute to metabolic health by improving insulin sensitivity and regulating lipid metabolism, suggesting possible applications in managing diabetes and obesity.

Due to these multifaceted effects, Dehydroglyasperin D is of interest in nutraceutical and pharmaceutical development, particularly in formulations aimed at promoting longevity and preventing chronic diseases.